Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism KRAS inhibitors(GTPase KRas inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | Switzerland | 28 Apr 2025 | |
Colorectal Cancer | Preclinical | United States | 28 Apr 2025 | |
Leiomyosarcoma | Preclinical | United States | 28 Apr 2025 | |
Leiomyosarcoma | Preclinical | Switzerland | 28 Apr 2025 | |
Lung Cancer | Preclinical | United States | 28 Apr 2025 | |
Lung Cancer | Preclinical | Switzerland | 28 Apr 2025 | |
Pancreatic Cancer | Preclinical | Switzerland | 28 Apr 2025 | |
Pancreatic Cancer | Preclinical | United States | 28 Apr 2025 | |
Stomach Cancer | Preclinical | United States | 28 Apr 2025 | |
Stomach Cancer | Preclinical | Switzerland | 28 Apr 2025 |